MicroRNA-214 exerts a Cardio-protective effect by inhibition of fibrosis

Anatomical Record

Volumn 299, Issue 10, 2016, Pages 1348-1357

  Dong, Hua ^a   Dong, Shimin ^a   Zhang, Lisi ^a   Gao, Xueping ^a   Lv, Guangwei ^a   Chen, Wei ^a   Shao, Suxia ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

collagen; miR 214; MMP 1 TIMP 1; myocardial fibrosis; TGF 1

Indexed keywords

ADENOVIRUS VECTOR; ANGIOTENSIN II; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; INTERSTITIAL COLLAGENASE; MICRORNA 214; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; MICRORNA; MIRN214 MICRORNA,RAT;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HEART FIBROBLAST; HEART MUSCLE FIBROSIS; HEART PROTECTION; IN VITRO STUDY; IN VIVO STUDY; MALE; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; VIRAL GENE THERAPY; WESTERN BLOTTING; ANIMAL; CARDIAC MUSCLE; DISEASE MODEL; DRUG EFFECTS; FIBROBLAST; FIBROSIS; GENETICS; HEART; HEART INFARCTION; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II; ANIMALS; COLLAGEN TYPE I; COLLAGEN TYPE III; DISEASE MODELS, ANIMAL; FIBROBLASTS; FIBROSIS; HEART; MALE; MICRORNAS; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84987725291     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.23396     Document Type: Article

References (32)

1. Aurora AB, Mahmoud AI, Luo X, Johnson BA, van Rooij E, Matsuzaki S, Humphries KM, Hill JA, Bassel-Duby R, Sadek HA, Olson EN. 2012. MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca(2)(+) overload and cell death. J Clin Invest 122:1222–1232.
2. Benjamin MM, Khalil RA. 2012. Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease. Exs 103:209–279.
3. Chen K, Chen J, Li D, Zhang X, Mehta JL. 2004. Angiotensin II regulation of collagen type I expression in cardiac fibroblasts: modulation by PPAR-gamma ligand pioglitazone. Hypertension 44:655–661.
4. Creemers EE, Pinto YM. 2011. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc Res 89:265–272.
5. Dai Y, Khaidakov M, Wang X, Ding Z, Su W, Price E, Palade P, Chen M, Mehta JL. 2013. MicroRNAs involved in the regulation of postischemic cardiac fibrosis. Hypertension 61:751–756.
6. Denby L, Ramdas V, Lu R, Conway BR, Grant JS, Dickinson B, Aurora AB, McClure JD, Kipgen D, Delles C, van Rooij E, Baker AH. 2014. MicroRNA-214 antagonism protects against renal fibrosis. J Am Soc Nephrol 25:65–80.
7. Dong S, Cheng Y, Yang J, Li J, Liu X, Wang X, Wang D, Krall TJ, Delphin ES, Zhang C. 2009. MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem 284:29514–29525.
8. Fang J, Song XW, Tian J, Chen HY, Li DF, Wang JF, Ren AJ, Yuan WJ, Lin L. 2012. Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes. Apoptosis 17:410–423.
9. Fihn SD, Vaughan-Sarrazin M, Lowy E, Popescu I, Maynard C, Rosenthal GE, Sales AE, Rumsfeld J, Pineros S, McDonell MB, Helfrich CD, Rusch R, Jesse R, Almenoff P, Fleming B, Kussman M. 2009. Declining mortality following acute myocardial infarction in the Department of Veterans Affairs Health Care System. BMC Cardiovasc Disord 9:44.
10. Guo H, Ingolia NT, Weissman JS, Bartel DP. 2010. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466:835–840.
11. Heeneman S, Cleutjens JP, Faber BC, Creemers EE, van Suylen RJ, Lutgens E, Cleutjens KB, Daemen MJ. 2003. The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis. J Pathol 200:516–525.
12. Iizuka M, Ogawa T, Enomoto M, Motoyama H, Yoshizato K, Ikeda K, Kawada N. 2012. Induction of microRNA-214-5p in human and rodent liver fibrosis. Fibrogenesis Tissue Repair 5:12.
13. Iwata M, Cowling RT, Yeo SJ, Greenberg B. 2011. Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure. J Mol Cell Cardiol 51:542–547.
14. Li L, Fan D, Wang C, Wang JY, Cui XB, Wu D, Zhou Y, Wu LL. 2011. Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-beta1 pathways in cardiac fibroblasts. Cardiovasc Res 91:80–89.
15. Lijnen P, Petrov V, van Pelt J, Fagard R. 2008. Inhibition of superoxide dismutase induces collagen production in cardiac fibroblasts. Am J Hypertension 21:1129–1136.
16. Lijnen PJPJ, van Peltet JF, Lijnen PJ, Fagard RH. 2011. Modulation of reactive oxygen species and collagen synthesis by angiotensin II in cardiac fibroblasts. Open Hypertension J 4:1–17.
17. Lijnen PJ, van Pelt JF, Fagard RH. 2012. Stimulation of reactive oxygen species and collagen synthesis by angiotensin II in cardiac fibroblasts. Cardiovasc Ther 30:e1–e8.
18. Lv G, Shao S, Dong H, Bian X, Yang X, Dong S. 2014. MicroRNA-214 protects cardiac myocytes against H2O2-induced injury. J Cell Biochem 115:93–101.
19. Okada H, Honda M, Campbell JS, Takegoshi K, Sakai Y, Yamashita T, Shirasaki T, Takabatake R, Nakamura M, Tanaka T, Kaneko S. 2015. Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice. Cancer Sci 106:1143–1152.
20. Pan Z, Zhao W, Zhang X, Wang B, Wang J, Sun X, Liu X, Feng S, Yang B, Lu Y. 2011. Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFbeta1 expression and activation of p38-MAPK and ERK1/2. Br J Pharmacol 162:688–700.
21. Patel BM, Mehta AA. 2012. Aldosterone and angiotensin: Role in diabetes and cardiovascular diseases. Eur J Pharmacol 697:1–12.
22. Salloum FN, Yin C, Kukreja RC. 2010. Role of microRNAs in cardiac preconditioning. J Cardiovasc Pharmacol 56:581–588.
23. Suh JH, Choi E, Cha MJ, Song BW, Ham O, Lee SY, Yoon C, Lee CY, Park JH, Lee SH, Hwang KC. 2012. Up-regulation of miR-26a promotes apoptosis of hypoxic rat neonatal cardiomyocytes by repressing GSK-3beta protein expression. Biochem Biophys Res Commun 423:404–410.
24. van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN. 2008. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 105:13027–13032.
25. Vijayaraghavan K, Deedwania P. 2011. Renin-angiotensin-aldosterone blockade for cardiovascular disease prevention. Cardiol Clin 29:137–156.
26. Wang B, Omar A, Angelovska T, Drobic V, Rattan SG, Jones SC and, Dixon IMC. 2007. Regulation of collagen synthesis by inhibitory Smad7 in cardiac myofibroblast. Am J Physiol Heart Circ Physiol 293:H1282–H1290.
27. Weber KT, Sun Y, Katwa LC, Cleutjens JP, Zhou G. 1995. Connective tissue and repair in the heart. Potential regulatory mechanisms. Ann NY Acad Sci 752:286–299.
28. Xie Y, Chen J, Han P, Yang P, Hou J, Kang YJ. 2012. Immunohistochemical detection of differentially localized up-regulation of lysyl oxidase and down-regulation of matrix metalloproteinase-1 in rhesus monkey model of chronic myocardial infarction. Exp Biol Med (Maywood) 237:853–859.
29. Xue SRLZ, Xu CS, Yan QE, Jiang HL, Wu HC, Tang CS. 2006. [Effects of proadrenomedullin N-terminal 20 peptide on angiotensin II-induced NO production in rat cardiac fibroblasts]. Nan Fang Yi Ke Da Xue Xue Bao 26:936–938.
30. Yang L, Zou XJ, Gao X, Chen H, Luo JL, Wang ZH, Liang QS, Yang GT. 2009. Sodium tanshinone IIA sulfonate attenuates angiotensin II-induced collagen type I expression in cardiac fibroblasts in vitro. Exp Mol Med 41:508–516.
31. Yang T, Zhang GF, Chen XF, Gu HH, Fu SZ, Xu HF, Feng Q, Ni YM. 2013. MicroRNA-214 provokes cardiac hypertrophy via repression of EZH2. Biochem Biophys Res Commun 436:578–584.
32. Zhang YL, Zhou SX, Lei J, Yuan GY, Wang JF. 2008. Blockades of angiotensin and aldosterone reduce osteopontin expression and interstitial fibrosis infiltration in rats with myocardial infarction. Chin Med J (Engl) 121:2192–2196.